Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
A R MüllerJ R ZinkstokN N J RommelseP M van de VenK C B RoesF A WijburgE de Rooij-AskesC LindersE BootAgnies M van EeghenPublished in: Orphanet journal of rare diseases (2021)
This study is registered in the Netherlands Trial Register (NTR9125).